To address this knowledge gap, we conducted a retrospective cohort study to assess the clinical impact of combination therapy compared to SGLT2i monotherapy in patients with MASLD
The type of L-Carnitine you are consuming (substantially faster absorption for liquid product vs
The competitive landscape is intensifying with over 60 late-stage pipeline assets in China and looming semaglutide biosimilars, escalating pressure on pricing, differentiation and market access
Metabolic diseases Type 2 diabetes mellitus GLP-1RAs are well-established treatments for T2DM, enhancing insulin secretion and suppressing glucagon release in a glucose-dependent manner, thereby improving glycaemic control [108, 214]
However, these approaches face critical delivery challenges, including poor tumor penetration, rapid systemic clearance, and off-target toxicity, necessitating nanomaterials-mediated targeted delivery systems to achieve tumor-specific accumulation and enhanced therapeutic precision